VCA Inc. (NASDAQ:WOOF) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Friday, September 1st. The firm presently has a $104.00 target price on the stock. Zacks Investment Research‘s target price suggests a potential upside of 11.85% from the stock’s previous close.
According to Zacks, “VCA Inc. is a national animal healthcare company operating primarily in the United States and Canada. It owns, operates and manages veterinary hospitals and veterinary-exclusive clinical laboratories in the country, supplies diagnostic imaging equipment and other medical technology products and related services to the veterinary industry, and provides various communication, professional education and marketing solutions to the veterinary community. VCA Inc., formerly known as VCA Antech, Inc., is headquartered in Los Angeles, California. “
A number of other research firms have also recently issued reports on WOOF. BidaskClub cut shares of VCA from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 9th. Stifel Nicolaus reiterated a “hold” rating and issued a $93.00 price objective on shares of VCA in a research note on Friday, July 14th. One research analyst has rated the stock with a sell rating, eight have given a hold rating, one has given a buy rating and one has given a strong buy rating to the company. VCA presently has a consensus rating of “Hold” and an average price target of $92.17.
Shares of VCA (NASDAQ WOOF) opened at 92.98 on Friday. The company has a market cap of $7.56 billion, a price-to-earnings ratio of 34.94 and a beta of 1.01. VCA has a 12 month low of $59.51 and a 12 month high of $93.00. The company’s 50-day moving average price is $92.72 and its 200-day moving average price is $92.11.
VCA (NASDAQ:WOOF) last posted its earnings results on Wednesday, July 26th. The company reported $0.96 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.02. The company had revenue of $743.13 million during the quarter, compared to analysts’ expectations of $735.75 million. VCA had a net margin of 8.00% and a return on equity of 15.54%. During the same quarter in the prior year, the company posted $0.87 earnings per share. Analysts anticipate that VCA will post $3.23 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://ledgergazette.com/2017/09/17/vca-inc-woof-upgraded-by-zacks-investment-research-to-buy-2.html.
Several large investors have recently bought and sold shares of the company. BlackRock Inc. lifted its stake in shares of VCA by 14.9% in the second quarter. BlackRock Inc. now owns 7,282,530 shares of the company’s stock worth $672,251,000 after buying an additional 941,647 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of VCA by 2.5% in the second quarter. Vanguard Group Inc. now owns 6,384,738 shares of the company’s stock worth $589,375,000 after buying an additional 155,054 shares in the last quarter. Bank of America Corp DE lifted its stake in shares of VCA by 267.3% in the first quarter. Bank of America Corp DE now owns 2,624,862 shares of the company’s stock worth $240,175,000 after buying an additional 1,910,155 shares in the last quarter. State Street Corp lifted its stake in shares of VCA by 21.1% in the second quarter. State Street Corp now owns 2,510,433 shares of the company’s stock worth $231,737,000 after buying an additional 436,985 shares in the last quarter. Finally, Pentwater Capital Management LP purchased a new position in shares of VCA in the first quarter worth about $214,110,000. 76.52% of the stock is currently owned by hedge funds and other institutional investors.
VCA Inc is an animal healthcare company operating in the United States and Canada. The Company operates through five segments: animal hospitals (Animal Hospital), veterinary diagnostic laboratories (Laboratory), veterinary medical technology (Medical Technology), Vetstreet and Camp Bow Wow Franchising, Inc (Camp Bow Wow).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for VCA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VCA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.